KromaTiD

KromaTiD is committed to advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetic analyses and reagents. KromaTiD provides customized assay development services as well as support for clinical and preclinical trial research. dGH is a next-generation cyto-genomics platform with broad applications in fields such as gene editing and biodosimetry.